Skip to content

The Aesthetic Surgery Education and Research Foundation

Physician Initiated Research
Evaluation of Breast Implant–Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing Print
Neha Akkad, MD, Rohan Kodgule, MD, Eric J Duncavage, MD, Neha Mehta-Shah, MD, MSCI, David H Spencer, MD, PhD, Marcus Watkins, PhD, Cara Shirai, PhD, Terence M Myckatyn, MD, FACS, FRCSC

Aesthetic Surgery Journal, sjac282

Background: Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare malignancy originating from the periprosthetic capsule of a textured, most often macrotextured, breast implant. Identified in women whose indications for breast implants can be either aesthetic or reconstructive, the genomic underpinnings of this disease are only beginning to be elucidated.

Objectives: The aim of this study was to evaluate the exomes, and in some cases the entire genome, of patients with BIA-ALCL. Specific attention was paid to copy number alterations, chromosomal translocations, and other genomic abnormalities overrepresented in patients with BIA-ALCL.  

>> View on the Aesthetic Surgery Journal  Website
 
Microbes, Histology, Blood Analysis, Enterotoxins, and Cytokines: Findings From the ASERF Systemic Symptoms in Women–Biospecimen Analysis Study: Part 3 Print
Patricia McGuire, MD, Caroline Glicksman, MD, MSJ, Roger Wixtrom, PhD, C James Sung, MD, FCAP, Robert Hamilton, PhD, D(ABMLI), Marisa Lawrence, MD, Melinda Haws, MD, Sarah Ferenz, BA, Marshall Kadin, MD

Aesthetic Surgery Journal, sjac225

Background: There has been an increasing need to acquire rigorous scientific data to answer the concerns of physicians, patients, and the FDA regarding the self-reported illness identified as breast implant illness (BII). There are no diagnostic tests or specific laboratory values to explain the reported systemic symptoms described by these patients.

Objectives: The aim of this study was to determine if there are quantifiable laboratory findings that can be identified in blood, capsule tissue pathology, or microbes that differentiate women with systemic symptoms they attribute to their implants from 2 control groups.  

>> View on the Aesthetic Surgery Journal  Website

 
A Randomized, Placebo-Controlled Trial Evaluating the Single and Combined Efficacy of Radiofrequency and Hybrid Fractional Laser for Nonsurgical Aesthetic Genital Procedures in Post-Menopausal Women Print
Christine Wamsley, BA, Mikaela Kislevitz, MD, BSN, RN, Nicole R Vingan, BS, Sydney Oesch, MD, Karen Lu, MD, Jennifer Barillas, BS, John Hoopman, CMLSO, Yucel Akgul, MD, PhD, Deniz Basci, MD, Kimberly Kho, MD, Phillipe E Zimmern, MD, Jeffrey M Kenkel, MD, FACS
 
Aesthetic Surgery Journal, sjac202

Background: The efficacy of interventions that provide long-term relief of genitourinary symptoms of menopause has not been determined.
 
Objectives: The authors sought to evaluate radiofrequency and hybrid fractional laser (HFL) treatments for menopausal vulvovaginal symptoms.   

>> View on the Aesthetic Surgery Journal  Website

 
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 15

"I GIVE..."

Jose López Tallaj
Santo Domingo, DR
Life Insurance Policy

“I give knowing that ASERF is the research foundation arm of the Society, which has had a positive impact on my practice.

I believe that as plastic surgeons we have a commitment to advance our specialty and standards and making a gift to ASERF makes that possible.”

The Aesthetic Society


Copyright © 2009-2018 ASERF. 11262 Monarch St., Garden Grove, CA 92841-1441 P: 800-364-2147 F: 562-799-1098